RESEARCH DISCIPLINE
Statistical Analysis for Experimental Pharmacology Research
Consulting for Preclinical & Mechanistic Studies
Experimental pharmacology statistical analysis for concentration-response curves, in vitro assays and in vivo dose studies, with potency estimated from fitted curves, replicates defined by independent experiments and results prepared to the standard your journal expects.
No Commitment Required
Strictly Confidential
In-House PhD-Level Statisticians
Fixed Project Fee
Same-Day Response
Statistical Analysis for Experimental Pharmacology Research
Experimental pharmacology statistical analysis is the statistical design, analysis and reporting of studies of how a compound acts, measured in cells, tissues and animals across a range of concentrations or doses. The data are curves, not group means: potency such as EC50 or IC50 must be estimated from a handful of concentrations, wells and plates supply replicates that are easily mistaken for independent samples, and one animal may be measured after every dose, so a workflow that tests each dose against control separately discards the shape of the response and its uncertainty. OnlineSPSS, a specialist statistical consultancy for academic, clinical and professional research, provides dose response analysis through in-house PhD-level statisticians, who fix the curve model, the replicate structure and the primary contrasts with you before any fit is reported.
WHEN TO ENGAGE
Statistical Support at Different Stages of Pharmacology Research
Pharmacology researchers usually contact us when a curve, a dose design or a reviewer's comment turns on a statistical decision.
Designing a Dose Study You are planning concentrations or doses for a new compound and need the number of levels, their spacing, the replicates and the primary contrast chosen before the first plate is run.
Fitting Response Curves Your plates or tissue baths have been read, and the curve model, the treatment of control wells and the estimate of EC50 or IC50 with its interval need to be settled and run.
Comparing Compounds You need to show that one compound is more potent than another, or that an antagonist shifts the curve, with a comparison that uses all the data and states its uncertainty.
Answering a Pharmacology Reviewer A reviewer has asked what n represents, why responses were normalized or why each dose was tested separately, and the reply has to show how the curves were built from independent experiments.
RESEARCH CONTEXT
Research Designs and Data We Work With in Pharmacology
Pharmacology data are series of responses across doses, and each design records them with a structure of dose groups, replicates and animals that the analysis has to follow.
01
Concentration-Response in Cells
Cells exposed to a range of concentrations in plate wells, run as independent experiments on different days with replicate wells inside each.
02
Isolated Tissue Preparations
Organ-bath or myograph tissues given cumulative concentrations, with several preparations per animal and curves compared between agonists and antagonists.
03
In Vivo Dose Groups
Animals allocated to several dose groups and a vehicle, with an endpoint such as latency, temperature or behavior measured in each animal.
04
Repeated Dosing in the Same Animals
Crossover or within-animal designs in which each animal receives several doses in sequence, with order and washout to take into account.
05
Time Courses and Exposure Profiles
Responses followed over time after dosing, summarized by peak, duration or area under the curve, with plasma concentrations sampled alongside.
06
Antagonist and Interaction Studies
Agonist curves repeated with fixed antagonist concentrations, or two drugs combined, to estimate shifts in potency and interaction.
METHODOLOGICAL CONSIDERATIONS
Statistical Issues We Consider in Pharmacology Research
These are the checks made in preclinical study statistics before a potency or an effect is reported, because the curve model and the replicate structure change an estimate more than a test does.
What n Means in a Curve Study One curve fitted to the pooled wells of several days hides the day-to-day variation. Each independent experiment, with fresh cells or tissue, gives its own curve, and potency is summarized across those curves.
Curve Model Before Test A four-parameter logistic model estimates bottom, top, slope and EC50. A parameter is fixed only for a stated reason, such as a bottom set by the vehicle control, and the choice is made before fitting.
Curves That Do Not Plateau When a compound fails to reach a plateau within the range tested, its EC50 is poorly determined. The interval is reported as it is, or as a bound on potency, instead of a precise number the data cannot support.
Potency on the Log Scale Concentrations are spaced on a log scale and potency is analyzed as log EC50 or pEC50, whose estimates are closer to symmetric, so ratios and intervals between compounds are formed on that scale.
Normalization to Control A response expressed as a percentage of control carries the noise of that control. Where normalization is used, the control is treated as measured with error and the raw values are kept for the fit.
Doses, Endpoints and the Primary Contrast Several doses and endpoints multiply comparisons. The primary contrast, such as each dose against vehicle or a trend across doses, is named in advance and carries a Dunnett-type or hierarchical adjustment.
STATISTICAL METHODS
Methods Selected for the Research Question and Study Design
Each method family is chosen for the response type and the dosing design of your study, and the line under each title explains why it suits pharmacology data.
Regression & Predictive Modeling
Concentration-response curves are fitted as nonlinear regressions, quantal responses with logistic models and Schild plots with linear regression, each giving potency with an interval.
Longitudinal & Multilevel Analysis
Doses given in sequence to the same animals and curves from several preparations per animal take animal-level random effects, in generalized form for counts or all-or-none responses.
Comparative & Hypothesis Testing
Doses are compared with vehicle as one family with a Dunnett-type adjustment, and doses given to the same animals use paired or repeated measures analyses, not unadjusted t-tests.
Bayesian & Computational Methods
When intervals from a curve with few points are unreliable, bootstrap and profile-likelihood intervals are compared with them, and simulation sets how many concentrations a design needs.
Clinical, Survival & Epidemiological
Latency and survival endpoints, such as time to seizure or survival after a challenge, are censored at the end of observation, which survival methods handle and a mean latency does not.
Evidence Synthesis & Meta-Research
Potency or effect estimates for a compound, gathered by a systematic search of preclinical studies, are pooled on a common scale with a random-effects model, or deliberately not pooled.
DELIVERABLES
Statistical Outputs Prepared for Your Research
The outputs follow the structure of a dose-response study, from the review of the concentration series to the files that regenerate each curve.
Data & Study Review The concentration series, the replicate structure, control wells, normalization and excluded runs are reviewed before a curve is fitted, so every n traces to an independent experiment or animal.
Statistical Analysis The agreed curve fits and comparisons, with residual and curve-fit diagnostics, a check of results with and without constrained parameters and the planned sensitivity analyses.
Effect Estimates & Uncertainty EC50 or IC50, slope and maximal response with 95% confidence intervals, potency ratios between compounds and absolute differences at chosen doses, on the log scale where appropriate.
Tables & Figures Curve plots with every replicate shown, potency tables, overlays of the compounds compared and a table of experiments, animals and exclusions.
Statistical Interpretation Potency and efficacy are explained in pharmacological terms within what the design supports, incomplete curves are reported as such and the limits of the tested range are stated.
Analysis Files R scripts, GraphPad Prism files or SAS programs, with the plate or animal structure and the curve settings documented so that every fit can be regenerated.
REPORTING
Reporting Pharmacology Research
Pharmacology journals ask for more than a p value, and the guidance that applies depends on whether the work is in vitro, in vivo or both.
In vivo dose studies report to ARRIVE 2.0, which in a pharmacology paper means stating the dose groups, how animals were allocated to them, who was blinded to dose and why any animal was removed. The British Journal of Pharmacology guidance on experimental design and analysis, which that journal requires of its authors, counts group size as the number of independent values, asks for at least five per group before statistical analysis is applied and separates exploratory from hypothesis-testing studies. Potency is reported with its confidence interval and the number of independent experiments behind it, and every replicate is visible in the figures. The Transparency and Openness Promotion Guidelines (TOP 2025) apply where a journal has adopted them.
ILLUSTRATIVE EXAMPLE
How the Analysis May Look in Practice
An illustration of how a potency comparison built on pooled wells is rebuilt around independent experiments and fitted curves.
ILLUSTRATIVE EXAMPLE · RECEPTOR ANTAGONIST POTENCY RESEARCH · UNITED STATES
A pharmacology group at a nonprofit research institute wanted to compare the potency of a new receptor antagonist with a reference compound in cultured cells.
Each compound was tested across a full concentration series in triplicate wells, and the experiment was repeated on several days with freshly thawed cells. In the first draft every well had been counted as a separate sample. The analysis plan was set before any curve was refitted: the independent experiment as the unit, a four-parameter logistic curve for each experiment with the bottom fixed at the vehicle level, log IC50 as the quantity compared and a random term for experiment day. The weaker compound did not reach a full plateau at the highest concentration, so its interval was checked with profile-likelihood and bootstrap methods and the limitation was stated.
Outcome: The group received the log IC50 of each compound with its 95% confidence interval, the potency ratio with its interval, curve plots showing every replicate, a methods paragraph and the scripts.
This example does not describe a real client or project. We never share details of actual client work, in line with the confidentiality we promise every researcher. This illustrative example is included to show the type, scope, and standard of work involved in this kind of analysis.
RESEARCHER VOICE
What Researchers Say
Feedback from a pharmacology researcher on the repeated or paired structure of the measurements, and on tables and interpretation that read as pharmacology rather than a generic template.
“Our project had a very field-specific problem around the repeated or paired structure of the measurements. The team understood why it mattered in Pharmacology and chose the analysis accordingly. The final tables and interpretation felt written for our research context rather than copied from a generic statistics template.”
HOW WE ASSESS YOUR PROJECT
We Review Your Actual Research
Your assessment is based on a review of your actual research materials and analytical requirements, not a generic project category.
You Submit Your Project Details
Share whatever is available at the current stage, such as the research aim, protocol or proposal, dataset, variable list, manuscript or statistical requirements.
We Review Your Research and Define the Scope
Your statistically trained Research Coordinator reviews the materials to understand the study design, research questions, data structure, analytical requirements and expected deliverables. If clarification is needed, additional documents or information can be requested before the assessment is finalized.
Your Analysis Is Completed and Delivered
Once the scope and fixed project fee are agreed, the in-house statistician completes the work and the Research Coordinator remains the communication point through delivery, with the analysis, deliverables and timeline as agreed.
SOFTWARE
Statistical Software for Pharmacology Research
Dose-response analyses are run in the tools your laboratory uses, with curve fitting in Prism or R and larger designs in SAS or Python, and files provided where applicable.
Statistical Support Within Your Research OnlineSPSS provides the agreed methodological, analytical, and statistical reporting support. The researcher or research team retains the scientific question, substantive interpretation, conclusions, and overall responsibility for the research.
FREQUENTLY ASKED QUESTIONS
Questions About Statistical Analysis for Experimental Pharmacology
Short answers to what pharmacology researchers ask before sharing a study, from curve fitting and replicates to scope, confidentiality and the assessment process.
Which statistical methods suit preclinical pharmacology data?
Preclinical pharmacology data analysis usually starts from the curve: drug response modeling by nonlinear regression gives potency, slope and maximal response with intervals, and in vivo dose groups use models that respect repeated measurements in each animal. Which approach applies depends on whether the question concerns potency, efficacy or a shift of the curve. Our Statistical Methods pages show how each family is applied.
Why fit a curve instead of testing each dose?
A fitted curve uses every concentration at once, so potency, slope and maximal response come with intervals that no set of dose-by-dose tests can provide. Where the aim is a comparison at a few fixed doses, as in many in vivo studies, the comparisons are made as one family with a stated adjustment.
How do you analyze antagonist and Schild experiments?
Antagonist experiments are analyzed by fitting the agonist curves at every antagonist concentration together, so the shift in potency and its uncertainty come from all the data at once. The dose ratios give a Schild slope, which is compared with 1 before a pA2 or pKB is reported, since a slope that departs from 1 points away from simple competitive antagonism. Each independent experiment contributes one set of curves, and the estimate is reported with its interval.
Does this page cover medication use in patients?
No. This page concerns experimental pharmacology: concentration-response work, in vitro assays and in vivo dose studies. Research on medicines as they are used by patients, with dispensing records, adherence measures and pharmacoepidemiologic designs, belongs under Pharmacy & Pharmacology.
How is confidential pharmacology data handled?
Raw assay data, compound information, experimental protocols and analysis files are handled confidentially, and project information is not published. An NDA is available where required and can be arranged before sensitive materials are shared. Read more about confidentiality and data security.
What happens when I request an assessment, and how long does it take?
You share your research question, design and relevant materials, and a statistically trained Research Coordinator reviews the request and responds the same day. The analysis, deliverables, timeline and one fixed project fee are then confirmed before any work begins, so the timeline follows from the agreed scope.
Still have a question? Find more answers in our full FAQ.
NEXT STEP
Discuss Your
Pharmacology Research With Us
Share your research question, dosing design and available data, even if only a concentration series or a draft figure exists. We check which independent experiments stand behind each curve and confirm the approach first.
No Commitment Required
Strictly Confidential
Fixed Project Fee
In-House PhD-Level Statisticians
Same-Day Response
Serving Researchers Since 2014